Micrus Endovascular Corporation (MEND) Receives Approval to Market DeltaPaq and DeltaPlush Microcoils in Japan
6/17/2010 8:52:14 AM
SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (NASDAQ:MEND) today announced receipt of Shonin approval from the Ministry of Health, Labour and Welfare to market in Japan its novel bare platinum and Cerecyte® DeltaPaq™ filling and DeltaPlush™ finishing microcoils for the treatment of cerebral aneurysms and treatments in the peripheral vasculature. DeltaPaq and DeltaPlush microcoils feature Micrus Endovascular’s Delta Wind™ technology, which is designed to achieve greater intra-aneurysmal packing density than conventional microcoils. Sales of DeltaPaq and DeltaPlush microcoils in Japan will be managed by Goodman Co., Ltd., Micrus Endovascular’s exclusive distributor in the Japanese market.